EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION
                     906 OF THE SARBANES-OXLEY ACT OF 2002



         In connection with the Quarterly Report of Elite Pharmaceuticals,  Inc.
(the  "Company") on Form 10-Q for the quarter ended December 31, 2003 filed with
the Securities and Exchange  Commission (the "Report"),  I, Bernard Berk,  Chief
Executive Officer of the Company,  certify, pursuant to 18 U.S. C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

         (1)  The Report fully complies with the  requirements  of Section 13(a)
              of the Securities Exchange Act of 1934; and

         (2)  The information  contained in the Report fairly  presents,  in all
              material  respects,  the consolidated  financial  condition of the
              Company as of the dates presented and the  consolidated  result of
              operations of the Company for the periods presented.


                                    /s/ Bernard Berk
Date:    February 13, 2004          _____________________________
                                    Bernard Berk
                                    Chief Executive Officer of
                                    Elite Pharmaceuticals, Inc.


This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided  to  Elite  Pharmaceuticals,   Inc.  and  will  be  retained  by  Elite
Pharmaceuticals, Inc. and furnished to the Securities and Exchange Commission or
its staff upon request.